Track the 신라젠 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 신라젠 has recorded 33 insider filings. The latest transaction was disclosed on 2 July 2025 (Purchase). Among the most active insiders: 엠투엔. All data is openly available.
33
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.